Beatrice Borchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Beatrice Borchi has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
Annalisa Cavallo
Infectious and Tropical Diseases Unit Careggi University Hospital Florence Italy
2 shared publicationsA. Agangi
1 shared publicationA. Bucceri
1 shared publicationA. Capone
1 shared publicationA. Cerioli
1 shared publicationA. Citernesi
1 shared publication
Latest Publications
- 14 July 2020
- Published by Wiley in Transplant Infectious Disease
- Vol. 22 (4) , e13286
Threatening drug‐drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID‐19)
During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long‐term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36‐year‐old kidney‐transplanted woman affected by Senior‐Loken syndrome diagnosed with COVID‐19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough, and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after 2 days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case report. We stress the need for guidelines in transplant recipients with COVID‐19 infection with particular regard to the management of therapy.
- 14 July 2020
- Published by Wiley in Transplant Infectious Disease
- Vol. 22 (4) , e13286
Threatening drug‐drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID‐19)
During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long‐term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36‐year‐old kidney‐transplanted woman affected by Senior‐Loken syndrome diagnosed with COVID‐19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough, and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after 2 days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case report. We stress the need for guidelines in transplant recipients with COVID‐19 infection with particular regard to the management of therapy.
- 1 September 2016
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22 (9) , 818-820
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV
- 1 September 2016
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22 (9) , 818-820
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV
- Open Access
- 12 April 2016
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 71 (8) , 2349-2351
Linezolid-resistantcfr-positive MRSA, Italy
WGS analysis combined with SCCmec typing9 assigned the strain to the ST5-MRSA-II lineage and spa type t306. ST5-MRSA-II is a globally widespread lineage,10 acco
- 12 April 2016
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 71 (8) , 2349-2351
Open AccessLinezolid-resistantcfr-positive MRSA, Italy
WGS analysis combined with SCCmec typing9 assigned the strain to the ST5-MRSA-II lineage and spa type t306. ST5-MRSA-II is a globally widespread lineage,10 acco